Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
49,779,938
-
Total 13F shares
-
47,693,431
-
Share change
-
+288,334
-
Total reported value
-
$1,220,447,234
-
Price per share
-
$25.59
-
Number of holders
-
92
-
Value change
-
-$168,216
-
Number of buys
-
53
-
Number of sells
-
34
Institutional Holders of Theravance Biopharma, Inc. - Common Stock (TBPH) as of Q4 2018
As of 31 Dec 2018 Theravance Biopharma, Inc. - Common Stock (TBPH) had 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 47,693,431 shares of stock of the company.
Largest 10 holders included Woodford Investment Management Ltd, BAUPOST GROUP LLC/MA, FMR LLC, Vanguard Group Inc, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Cormorant Asset Management, LP, STATE STREET CORP, NORGES BANK, and MORGAN STANLEY.
This table shows 92 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.